Tag Archives: China
By Pharm Exec | Published: September 26, 2014
The European Federation of Pharmaceutical Industries and Associations (EFPIA) reports that it has “strengthened its commitment in China”. Federation delegates are this week concluding a visit to Beijing to establish “a better understanding of the numerous healthcare reforms underway in China … and explore closer paths of cooperation in global drug development between China and […]
By Guest Blogger | Published: September 12, 2014
The Chinese market is attractive to foreign investors for many reasons. It is the world’s third largest market for pharmaceuticals with annual sale of US$71 billion. In fact, it is poised to become the second largest market in 2015 given that its annual growth rate of sales is between 15 and 20%, according to Yanzhong […]
By Pharm Exec | Published: August 26, 2014
China overtook Japan as the world’s second-biggest healthcare market in 2013, and with its annual healthcare spending forecast to reach nearly US$900bn by 2018, it will rapidly close the gap on the US, reports the Economist Intelligence Unit (EIU). EIU’s China Healthy Province Index (CHPI) provides a detailed healthcare profile of each of China’s 31 provinces,ranking provinces […]
By Pharm Exec | Published: March 21, 2014
Supply chains risks in China still include extremely high levels of corruption, environmental pollution issues and slow working conditions reforms, according to new analysis from Sedex.
By Julian Upton | Published: February 26, 2014
Bioscience research in China is set to overtake the United States within the next five to ten years, according to data from search engine CiteAb.